Treatment for Vaginal Strep agalactiae
Vaginal colonization with Group B Streptococcus (GBS/Streptococcus agalactiae) should NOT be treated with antibiotics outside of pregnancy or labor—treatment is reserved exclusively for the intrapartum period to prevent neonatal disease. 1
Key Clinical Decision Points
If the Patient is NOT Pregnant or NOT in Labor:
- Do not treat vaginal GBS colonization with antibiotics at any time outside of labor 1
- Prenatal antibiotic treatment is ineffective at eliminating carriage and does not prevent neonatal disease
- Treatment may cause adverse consequences including antibiotic resistance and allergic reactions
If the Patient IS Pregnant and in Labor:
The CDC guidelines provide clear, evidence-based algorithms for intrapartum antibiotic prophylaxis (IAP) based on penicillin allergy status 2:
For Women WITHOUT Penicillin Allergy:
First-line (preferred):
- Penicillin G: 5 million units IV initial dose, then 2.5-3.0 million units IV every 4 hours until delivery 2
- Penicillin is preferred due to its narrow spectrum of activity
Alternative:
- Ampicillin: 2 g IV initial dose, then 1 g IV every 4 hours until delivery 2
For Women WITH Penicillin Allergy:
You must first stratify the allergy risk:
Low-risk penicillin allergy (no history of anaphylaxis, angioedema, respiratory distress, or urticaria):
- Cefazolin: 2 g IV initial dose, then 1 g IV every 8 hours until delivery 2
High-risk penicillin allergy (history of anaphylaxis, angioedema, respiratory distress, urticaria, or asthma):
If GBS isolate is susceptible to both clindamycin AND erythromycin:
- Clindamycin: 900 mg IV every 8 hours until delivery 2
If susceptibility unknown, testing unavailable, or isolate resistant to either drug:
- Vancomycin: 1 g IV every 12 hours until delivery 2
Important Clinical Caveats
The Exception: GBS Bacteriuria in Pregnancy
If a pregnant woman has GBS bacteriuria with ≥100,000 CFU/mL, this should be treated at the time of diagnosis (not just at labor) with appropriate oral antibiotics, AND she should receive intrapartum prophylaxis regardless of colony count 3. This is the only scenario where prenatal treatment is indicated.
Timing Matters
- IAP is most effective when administered ≥4 hours before delivery 2
- However, never delay medically necessary obstetric procedures to achieve 4 hours of prophylaxis 2
Resistance Concerns
Recent data shows increasing resistance to clindamycin and erythromycin among GBS isolates 1, 4, 5. This is why:
- Erythromycin is no longer recommended as an alternative 2
- Susceptibility testing is critical for penicillin-allergic patients at high risk for anaphylaxis 2
- The M phenotype with mef(A) gene predominates in erythromycin-resistant isolates 5
What NOT to Do
- Do not treat asymptomatic vaginal GBS colonization outside of labor 1
- Do not use erythromycin for IAP in penicillin-allergic patients 2
- Do not treat male sexual partners—this does not prevent recurrence 6, 7
- Do not perform repeat GBS screening if bacteriuria was documented earlier in pregnancy 3
The Rationale
The entire strategy focuses on preventing early-onset neonatal GBS disease (occurring in the first week of life), which can cause sepsis, pneumonia, meningitis, and death 8. Maternal colonization itself causes no harm to the mother in most cases. IAP during labor reduces vertical transmission by up to 90% 9, resulting in an 80% reduction in early-onset disease where screening programs are implemented 9.
This approach prioritizes neonatal mortality and morbidity while minimizing unnecessary antibiotic exposure, allergic reactions, and antibiotic resistance development 1.